Obstructive sleep apnea - An important cardiovascular risk factor;Obstruktive Schlafapnoe - Ein wichtiger kardiovaskulärer Risikofaktor

Deutsches Arzteblatt

Volumn 103, Issue 12, 2006, Pages

  Schulz, Richard ^a   Eisele, Hans Joachim ^a   Weissmann, Norbert ^a   Seeger, Werner ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Arterial hypertension; Atherosclerosis; Cardiovascular disease; CPAP therapy; Sleep apnea

Indexed keywords

HUMORAL ANTIBODY;

ARTICLE; ATHEROSCLEROSIS; ATRIOVENTRICULAR BLOCK; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE PREDISPOSITION; ENDOTHELIUM LESION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART PROTECTION; HUMAN; HYPERTENSION; HYPOXIA; LONG TERM CARE; MICROENVIRONMENT; OXIDATIVE STRESS; POSITIVE END EXPIRATORY PRESSURE; PROGNOSIS; SINUS ARREST; SLEEP APNEA SYNDROME; STROKE; SYMPATHETIC TONE; VASODILATATION;

EID: 34247551153     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342: 1378-84.
2. Shahar E, Whitney CW, Redline S et al.: Sleep-disordered breathing and cardiovascular disease. Cross sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163: 19-25.
3. Schulz R: The vascular micromilieu in obstructive sleep apnoea. Eur Respir J 2005; 25: 780-2.
4. Schulz R, Mahmoudi S, Hattar K et al.: Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000; 162: 566-70.
5. Schulz R, Schmidt D, Blum A et al.: Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea - response to CPAP therapy. Thorax 2000; 55: 1046-51.
6. Lavie L, Vishnevsky A, Lavie P: Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004; 27: 123-8.
7. Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F: Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 2002; 165: 67-70.
8. Schulz R, Flötotto C, Jahn A et al.: Circulating adrenomedullin in obstructive sleep apnoea. J Sleep Res 2006; 15: 89-95.
9. Chin K, Nakamura T, Shimizu K et al.: Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 2000; 109: 562-7.
10. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP: Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997; 82: 1313-6.
11. Shamsuzzaman AS, Winnicki M, Lanfranchi P et al.: Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105: 2462-4.
12. Svatikova A, Wolk R, Shamsuzzaman AS, Kara T, Olson EJ, Somers VK: Serum amyloid a in obstructive sleep apnea. Circulation 2003; 108: 1451-4.
13. Ip MS, Tse HF, Lam B, Tsang KW, Lam WK: Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004; 169: 348-53.
14. Nieto FJ, Herrington DM, Redline S, Benjamin EJ, Robbins JA: Sleep apnea and markers of vascular endothelial function in a large Community sample of older adults. Am J Respir Crit Care Med 2004; 169: 354-60.
15. Grebe M, Eisele HJ, Weissmann N et al.: Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med; online veröffentlicht am 26. Januar 2006.
16. Gami AS, Howard DE, Olson EJ, Somers VK: Daynight pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005; 352: 1206-14.
17. Kanagala R, Murali NS, Friedman PA et al.: Obstructive sleep Apnea and the recurrence of atrial fibrillation. Circulation 2003; 107: 2589-94.
18. Gami AS, Pressman G, Caples SM et al.: Association of atrial fibrillation with obstructive sleep apnea. Circulation 2004; 110: 364-7.
19. Schulz R, Eisele HJ, Seeger W: Nocturnal atrial fibrillation in a patient with obstructive sleep apnoea. Thorax 2005; 60: 174.
20. Schulz R, Seeger W, Fegbeutel C et al.: Changes in extracranial arteries in obstructive sleep apnoea. Eur Respir J 2005; 25: 69-74.
21. Arzt M, Young T, Finn L, Skatrud JB, Bradley TD: Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005;172: 1447-51.
22. Marin JM, Carrizo SJ, Vicente E, Agusti AG: Long-term cardiovascular outcomes in men with obstructive sleep apnea-hypopnoea with and without treatment with continuous positive airway pressure: An observational study. Lancet 2005; 365: 1046-53.
23. Becker HF, Jerrentrup A, Ploch T et al.: Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68-73.
24. Martinez-Garcia MA, Galiano-Blancart R, Roman-Sanchez P, Soler-Cataluna JJ, Cabro-Salt L, Salcedo-Maiques E: Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest 2005; 128: 2123-9.
25. Kaneko Y, Floras JS, Usui K et al.: Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348: 1233-41.